Citius Pharmaceuticals, Inc. (CTXR)
0.5817
-0.02
(-3.37%)
USD |
NASDAQ |
Sep 04, 16:00
0.5817
0.00 (0.00%)
After-Hours: 19:14
Citius Pharmaceuticals Total Assets (Quarterly) : 142.26M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 142.26M |
| March 31, 2026 | 132.54M |
| December 31, 2025 | 140.39M |
| September 30, 2025 | 131.16M |
| June 30, 2025 | 127.68M |
| March 31, 2025 | 121.48M |
| December 31, 2024 | 120.70M |
| September 30, 2024 | 116.65M |
| June 30, 2024 | 97.09M |
| March 31, 2024 | 90.71M |
| December 31, 2023 | 97.40M |
| September 30, 2023 | 103.61M |
| June 30, 2023 | 110.40M |
| March 31, 2023 | 104.24M |
| December 31, 2022 | 111.71M |
| September 30, 2022 | 114.00M |
| June 30, 2022 | 120.32M |
| March 31, 2022 | 127.79M |
| December 31, 2021 | 137.52M |
| September 30, 2021 | 142.43M |
| June 30, 2021 | 146.59M |
| March 31, 2021 | 134.67M |
| December 31, 2020 | 35.31M |
| September 30, 2020 | 43.77M |
| June 30, 2020 | 38.40M |
| Date | Value |
|---|---|
| March 31, 2020 | 26.49M |
| December 31, 2019 | 24.98M |
| September 30, 2019 | 28.99M |
| June 30, 2019 | 25.54M |
| March 31, 2019 | 24.24M |
| December 31, 2018 | 28.08M |
| September 30, 2018 | 31.05M |
| June 30, 2018 | 23.83M |
| March 31, 2018 | 26.06M |
| December 31, 2017 | 28.47M |
| September 30, 2017 | 24.42M |
| June 30, 2017 | 21.57M |
| March 31, 2017 | 21.33M |
| December 31, 2016 | 21.48M |
| September 30, 2016 | 21.95M |
| June 30, 2016 | 23.01M |
| March 31, 2016 | 24.78M |
| December 31, 2015 | 0.3469M |
| September 30, 2015 | 0.7415M |
| June 30, 2015 | 0.9623M |
| March 31, 2015 | 0.7658M |
| December 31, 2014 | 0.8226M |
| September 30, 2014 | |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Citius Oncology, Inc. | 112.09M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 66.35M |
| Shareholders Equity (Quarterly) | 66.61M |
| Debt to Equity Ratio | 0.1077 |
| Current Ratio | 0.839 |
| Net Debt Paydown Yield | -7.53% |